CANTATA: A multicentre, phase II randomised controlled trial evaluating cabazitaxel versus docetaxel re-challenge for the treatment of metastatic Castrate Refractory Prostate Cancer, previously treated with docetaxel at inception of primary hormone therapy

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the CANTATA Trial Office.

Trial Documents

Links to the current protocol, Patient Information Sheet, Informed Consent Form are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter, Release of Medical Information Form etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the CANTATA Trial Office.

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Version Control List. Links to the Version Control Lists used in this trial are below in reverse date order.


Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

Case Report Form


Other Trial Documents

Summary of Products Characteristics


To date there are no publications for this trial.

News and Events

No current news or upcoming events

Contact Details

Chief Investigator
Professor Nicholas James
Cancer Centre, 3rd Floor
Queen Elizabeth Hospital
B15 2TH

Tel:      +44 (0)121 371 3615 (Christine Hillman, Med Sec)
Fax:     +44 (0)121 371 3602

CANTATA Trial Office
Trial Coordinator:                              Nick Martin
Data Manager:                                   John Mason 
Trial Monitor:                                     Poonam Patel
Trial Management Team Leader:     Clive Stubbs
Trial Statistician:                               Dr Laura Buckley

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
B15 2TT

Telephone: +44 (0)121 414 6372
Fax:             +44 (0)121 414 2230

Trial Entry
Telephone: +44 (0)800 371 969 (9.00 am till 5.00 pm Monday to Friday)

Serious Adverse Event Reporting
Fax: +44 (0)121 414 2230 or +44 (0)121 414 3700

University of Birmingham